Indutrade AB: Indutrade Acquires Med-Tech Company

STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News:

Indutrade (STO:INDTB) today acquired all of the shares in EssMed AB, in Mölnlycke, Sweden, with annual sales of approximately SEK 60 million.

EssMed markets ophthalmology products and services. The company is a market leader in sales of equipment to private and public sector ophthalmology departments. EssMed also sells other medical products, including operation microscopes and pressure relief devices. The company has a subsidiary in Finland.

The acquisition of EssMed marks the entry into a new product segment for Indutrade, in the pharmaceutical industry. Organisationally, EssMed will be included in the Industrial Components business area, which had net sales of SEK 940 million in 2007.

The acquisition is expected to have a marginally positive impact on Indutrade's earnings per share.

About Indutrade

Indutrade markets and sells components, systems and services with a high-tech content within selected niches. Indutrade's business is distinguished by:

• High-tech products for recurring needs

• Growth through a structured and tried-and-tested acquisition strategy

• A decentralised organisation characterised by an entrepreneurial spirit

The Group is structured into four business areas: Engineering & Equipment, Flow Technology, Industrial Components and Special Products. Indutrade's sales totalled SEK 5 673 million in 2007, generating operating income of SEK 650 million before depreciation of intangible assets. Indutrade is listed on the OMX Nordic Exchange Stockholm.

This information was brought to you by Cision http://newsroom.cision.com